Doris Hafenbradl
Doris has enjoyed a successful career as scientist and corporate executive in the biotech and pharma industry in the US and Europe.
She joined Electrochaea from Axxam, a leading provider of integrated discovery services for the life sciences industry, where she was responsible for the company's discovery services activities.
Prior to Axxam, she held several senior management roles in international, industry-leading pharmaceutical firms including BioFocus, Proteros, GPC Biotech, Axxima Pharmaceuticals, Genomics Institute of the Novartis Research Foundation, and Diversa.
Doris dedicated her doctoral research in mircobiology to the study of hyperthermophilic archaea in the laboratory of Prof. Dr. Karl Stetter at the Archaea Centre at the University of Regensburg.